Ucb Biopharma Sprl competitive analysis

Explore patent oppositions filed by Ucb Biopharma Sprl against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 17, 2026
Patent NumberTitleApplicantOpposition Date
Culture Method For Obtaining A Clonal Population Of Antigen-Specific B CellsALDER BIOPHARMACEUTICALSAug 23, 2017
Binding Of Pathological Forms Of Prion ProteinsMICROSENS BIOPHAGESep 30, 2016
Method Of Stabilizing Antibody And Stabilized Solution-Type Antibody PreparationKYOWA HAKKO KIRINSep 30, 2016
A Method For Reducing Heterogeneity Of Antibodies And A Process Of Producing The Antibodies ThereofBIOCON RESEARCHAug 25, 2016
Stable Water-Based Medicinal Preparation Containing AntibodyKIRIN BEER KABUSHIKI KAISHAJun 7, 2016

Explore Ucb Biopharma Sprl's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 17, 2026
Patent NumberPublication DateTitleTotal Oppositions
May 10, 2023Novel Tnf Structure For Use In Therapy1
Aug 8, 2018Modified Antibody Fab Fragments1
Jun 6, 2018Polyvinylpyrrolidone For The Stabilization Of A Solid Dispersion Of The Non-Crystalline Form Of Rotigotine3
Jun 14, 2017Multi-Day Patch For The Transdermal Administration Of Rotigotine2

Latest PTAB cases involving Ucb Biopharma Sprl

Discover the latest PTAB cases involving Ucb Biopharma Sprl, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Ucb Biopharma Sprl with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 17, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
UCB BIOPHARMA SPRL56 - -
AMW62 - -
BIOCON RESEARCH - 8 - -
KYOWA HAKKO KIRIN - 16 - 3